Sepiapterin: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Sepiapterin. Educational only — not medical advice.
Labeled uses
SEPHIENCE is indicated for the treatment of hyperphenylalaninemia (HPA) in adult and pediatric patients 1 month of age and older with sepiapterin-responsive phenylketonuria (PKU). SEPHIENCE is to be used in conjunction with a phenylalanine (Phe)-restricted diet.
Source: FDA labeling via NIH DailyMed (set 9fabfee2…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.